Trials / Completed
CompletedNCT00529009
Pharmacokinetic Investigation of UDCA in Bile and Serum
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Dr. Falk Pharma GmbH · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
To assess the bile acid composition of cystic bile and serum pharmaco¬kinetics after a 3-week treatment with UDCA and to correlate pharmacokinetic parameters of UDCA in bile and serum during steady state.
Detailed description
see protocol
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UDCA |
Timeline
- Start date
- 2007-05-01
- First posted
- 2007-09-14
- Last updated
- 2019-05-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00529009. Inclusion in this directory is not an endorsement.